When the Trump administration ended, one of the issues that it left for the incoming administration was its proposal to withdraw a broad list of medicines and related products from U.S. commitments under the WTO Government Procurement Agreement
On October 30th, the Food and Drug Administration (FDA) published a list of essential medicines, medical countermeasures and critical inputs to comply with the president’s August 6 executive order. The U.S. Trade Representative (USTR) must take action